BMO Capital analyst Sean Dodge reiterated a Market Perform rating and $85.00 price target on HealthEquity, Inc (NASDAQ: HQY).

The analyst commented: "F4Q26 results were slightly ahead of consensus and consistent with February guidance orienting investors toward the high end of its prior range. Given the incremental strength in F4Q and continued momentum into the new year, HQY also raised its FY27 outlook (provided in January) as anticipated. The company continues to make encouraging progress on key initiatives including (1) the recent launch of its Marketplace offering—a new high margin revenue stream with little contribution contemplated in the guide; and (2) AI integration to further drive down service costs."

For an analyst ratings summary and ratings history on HealthEquity, Inc click here. For more ratings news on HealthEquity, Inc click here.

Shares of HealthEquity, Inc closed at $79.40 yesterday.